Generic Name and Formulations:
Sulfacetamide sodium 10%; oph. soln; contains benzalkonium chloride.
- Disaster Preparedness 101: Physician Resources for Patients
- Addressing the Uncertainties of the Public Service Loan Forgiveness Program for Medical School Graduates
- Greater Insight May Increase Hostility in Schizophrenia
Indications for BLEPH-10:
Susceptible infections of conjunctiva and cornea. Adjunct in trachoma.
Adults and Children:
<2months: not recommended. ≥2months: Conjunctivitis: 1–2 drops every 2–3 hrs during the day (less often at night). Trachoma: 2 drops every 2 hrs w. systemic therapy.
Purulent exudates may inactivate drug. Discontinue if hypersensitivity or rash occurs. Pregnancy (Cat.C). Nursing mothers: not recommended.
Incompatible with silver-containing preparations. May be antagonized by PABA.
Local irritation, stinging, burning, superinfection, sensitization.
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Lithium Monotherapy Effective in Treating Bipolar Disorder in Children
- Transdermal Nicotine Boosts Mood and Cognitive Function in Late-Life Depression
- Computerized Training Programs for Schizophrenia Improve Cognitive Functioning
- Cognitive Behavioral Therapy May Alter Suicidal Ideation in Anxiety Disorders
- Emerging Theories in the Pathophysiology of MDD: Could the Opioid System Be Involved?
- Antidepressant Effects of Ketamine Appear to Require Opioid System Activation
- Attention-Deficit/Hyperactivity Disorder Increasing Among US Children and Adolescents
- Cost-Effective Telehealth Alternatives for Veterans With Depression
- Polygenic Risk Scores Could Aid in Identifying Bipolar Disorder, Schizophrenia
- Brief Impression Questionnaire Useful in Schizophrenia Diagnoses